Target intelligence / Profile preview

Small nucleolar RNA SNORD116 (SNORD116)

Target
SNORD116
Molecular classification
Small nucleolar RNA, Non-coding RNA, Box C/D snoRNA, RNA gene
01

Overview

Small nucleolar RNA SNORD116 is a non-coding RNA of the box C/D snoRNA family, found in a tandemly repeated cluster within the imprinted 15q11–q13 region of human chromosome 15. Unlike typical snoRNAs, SNORD116 lacks known canonical targets and is thus referred to as an “orphan” snoRNA. It may guide 2′-O-methylation of yet-unidentified substrates, but it is also processed into long non-coding RNAs implicated in regulating mRNA splicing patterns and stability, particularly of genes rapidly induced in neurons. Loss of SNORD116 expression, due most commonly to paternal microdeletion, causes or contributes to the core symptoms of Prader–Willi syndrome, including neurodevelopmental, metabolic, and endocrine dysfunctions. SNORD116 is not currently considered a therapeutic drug target, nor are there drugs known to modulate its function. Its critical biological functions are still being characterized, but its unique roles in RNA metabolism, neuronal regulation, and imprinting make it a subject of intense biomedical research.

Other names
HBII-85snoHBII-85LOC124903255
02

Biological functions

Post-transcriptional modification of RNA (putative, as a member of box C/D snoRNAs, though not validated for ribosomal RNA targets)Regulation of mRNA stability (by direct binding and promoting degradation, especially in neuronal context)Regulation of pre-mRNA alternative splicing (via associated sno-lncRNAs)Potential role in nucleolar function and ribonucleoprotein assembly
03

Disease associations

Neurodevelopmental disorder (Prader–Willi syndrome; deletion causes key features of this syndrome)Other (Potential, due to involvement in neuronal gene regulation and metabolism)
04

Safety considerations

Not applicable, as SNORD116 is not a therapeutic target; deletion leads to Prader–Willi syndrome phenotype in humans
05

Biomarkers

Absence of SNORD116 expression in PWS is a potential diagnostic marker

Beyond the preview

Go deeper on Small nucleolar RNA SNORD116 (SNORD116).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA SNORD116 (SNORD116).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call